Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants — Stella

Recruiting

Back to Retinopathy of Prematurity trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

Sweden

Skåne University Hospital, Lund, Skåne County

Sahlgrenska University Hospital, Gothenburg, Västra Götaland County

Key details

Phase

Early testing

Sponsor

Region Skane

Enrollment target

~15 participants

Started

June 2022

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated March 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov